ÂÜÀòÂÒÂ×

Marcel Rozencweig is a seasoned executive in the biopharmaceutical industry, currently serving as President and CMO at NeoTX Therapeutics LTD since January 2015. Prior to this role, Marcel held the position of President at Innate Pharma Inc. from 2014 to 2017 and served as CMO at Innate Pharma from 2009 to 2014. Earlier in Marcel's career, a significant tenure was spent at Bristol Myers Squibb, where the title of VP was held from 1983 to 2001.